A Phase I Trial Of Pf-03084014 In Patients With Advanced Solid Tumor Malignancy And T-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
Phase of Trial: Phase I
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Nirogacestat (Primary) ; Dexamethasone
- Indications Precursor cell lymphoblastic leukaemia-lymphoma; Solid tumours
- Focus Adverse reactions
- Sponsors Pfizer
- 03 Apr 2017 Status changed from active, no longer recruiting to completed.
- 30 Nov 2016 Planned End Date changed from 1 Aug 2016 to 1 Nov 2016.
- 30 Nov 2016 Status changed from discontinued to active, no longer recruiting.